Advisory Services Network’s Anixa Biosciences ANIX Stock Holding History

Advisory Services Network’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-400	Closed	-$1.03K	–	2271
2026 Q1	$1.03K	Buy	+400	New	+$1.18K	﹤0.01%	4303
2025 Q4	–	Sell	-400	Closed	-$1.32K	–	1907
2025 Q3	$1.32K	Buy	+400	New	+$1.27K	﹤0.01%	3882
2024 Q4	–	Sell	-11,174	Closed	-$24.7K	–	1572
2024 Q3	$24.7K	Hold	11,174	–	–	﹤0.01%	1515
2024 Q2	$24.7K	Hold	11,174	–	–	﹤0.01%	1515
2024 Q1	$34.9K	Buy	11,174 +5,000	+81%	+$19.9K	﹤0.01%	1443
2023 Q4	$24K	Buy	+6,174	New	+$20.8K	﹤0.01%	2424
2023 Q2	–	Sell	-674	Closed	-$2.9K	–	1527
2023 Q1	$2.9K	Hold	674	–	–	﹤0.01%	3331
2022 Q4	$2.87K	Buy	+674	New	+$3.24K	﹤0.01%	3300
2021 Q3	–	Sell	-400	Closed	-$2K	–	1471
2021 Q2	$2K	Buy	+400	New	+$1.7K	﹤0.01%	3285
2021 Q1	–	Sell	-400	Closed	-$1K	–	1360
2020 Q4	$1K	Hold	400	–	–	﹤0.01%	3104
2020 Q3	$1K	Buy	+400	New	+$1.03K	﹤0.01%	3260

Other funds holding ANIX

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Advisory Services Network's ANIX Position: Q2 2026 in Review

Advisory Services Network sold out of Anixa Biosciences (ANIX) in Q2 2026, closing a stake of 400 shares — an estimated $1.03K sold.

Advisory Services Network first reported a position in ANIX in Q3 2020 and held it in 11 quarters. The position peaked at $34.9K in Q1 2024. 63 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

Advisory Services Network reported no remaining Anixa Biosciences position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 400 Anixa Biosciences shares in Q2 2026, an estimated $1.03K.
Advisory Services Network first reported a position in Anixa Biosciences in Q3 2020 and held it in 11 quarters.
Advisory Services Network's Anixa Biosciences position peaked at $34.9K in Q1 2024.
63 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.